Pharmaceutical Processing Seals Global Market Report 2022: Rise in Chronic Diseases Contributing Significantly to Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Processing Seals Global Market Report 2022, By Type, Material, Application” report has been added to ResearchAndMarkets.com’s offering. The global pharmaceutical processing seals market is expected to grow from $1.80 billion in 2021 to $2.03 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to … [Read more…]

DSG and 1nHealth Partner to Enhance Patient Outreach and Enrollment Capabilities

MALVERN, Pa.–(BUSINESS WIRE)–DSG, Inc., a global leader of eClinical software solutions and services, along with 1nHealth, a global digital patient recruitment provider, are creating a seamless participant experience from the initial study launch to completion of study participation. This includes integrating pre-screened leads from 1nHealth’s secure platform into DSG’s eCaseLink Enrollment Tracker to allow participants … [Read more…]

VAST Data Accelerates CeGaT Genetic Data Analytics, Delivering Medical Insights Significantly Faster Than Competing Hybrid Storage Solution

New all-flash data platform enables global genetic data analytics factory to quickly make discoveries from massive volumes of genomics sequence data, fueling medical breakthroughs Remote-First-Company/NEW YORK–(BUSINESS WIRE)–VAST Data, the data platform company for the AI-powered world, today announced the company was selected by CeGaT to accelerate time-to-insight for genetic analytics essential to diagnostic healthcare, genetic … [Read more…]

Ozette Announces $26MM in Series A Funding for AI-Powered Single-Cell Immune Discovery Technology that Accelerates Therapeutics Across Research and Development

Ozette’s proprietary technology eliminates manual gridlock and provides unmatched speed, resolution, and reproducibility to unlock immunotherapy breakthroughs from pre-clinical to post-market. SEATTLE–(BUSINESS WIRE)–Ozette Technologies, Inc., a technology-driven life sciences startup engineering a transformative leap in cell discovery and annotation of the human immune system, today announced its $26MM Series A funding, led by Madrona Ventures. … [Read more…]

Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company’s progress and priorities for 2022. Conference call details: Thursday, August 4, 2022 4:30 p.m. ET / 1:30 p.m. PT … [Read more…]

Propanc Biopharma’s CSO Reflects on Unique Anti-Cancer Effects of PRP Discovered Over Past Decade

Five Scientific Publications Underscores Proenzymes as an Effective Tool to Treat and Prevent Metastatic Cancer from Solid Tumors with Further Research in Progress MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that Chief Scientific Officer … [Read more…]

Diversified Healthcare Trust Expands its Portfolio of Life Science Properties In the San Francisco Bay Area Market with $82 Million Acquisition

NEWTON, Mass.–(BUSINESS WIRE)–Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has acquired 47071 Bayside Parkway located in Fremont, CA for $82 million, excluding closing costs, reflecting a current GAAP cap rate of 6.5% at closing. The recently renovated asset includes 89,000 rentable square feet of lab and corporate headquarters space that is 100% leased … [Read more…]

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent. Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years … [Read more…]

Silversmith Capital Partners Raises $1.25 Billion for Fourth Growth Equity Fund

BOSTON–(BUSINESS WIRE)–Silversmith Capital Partners (“Silversmith”) today announced the first and final close of its fourth fund, Silversmith Capital Partners IV (“Fund IV”). Launched in May 2022, Fund IV was significantly oversubscribed and closed at its target and hard cap of $1.25 billion. In addition to the $1.25 billion from limited partners, the Silversmith team will … [Read more…]

Prime Medicine Expands Leadership Team with Key Appointments to Support Continued Growth and Advancement of Prime Editing Technology and Portfolio

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prime Medicine, Inc. (“Prime Medicine”), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology, today announced the expansion of the company’s leadership team with the appointments of the following executives: Richard Brudnick as … [Read more…]